Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy

• Published in: Seminars in cancer biology Vol. 40-41; pp. 192 - 208
• Main Authors: Dandawate, Prasad R, Subramaniam, Dharmalingam, Jensen, Roy A, Anant, Shrikant
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01-10-2016
• Subjects: Animals; Antineoplastic Agents, Phytogenic - pharmacology; Antineoplastic Agents, Phytogenic - therapeutic use; Breast cancer; Breast Neoplasms - drug therapy; Breast Neoplasms - metabolism; Breast Neoplasms - pathology; Cancer stem cells; Cell Proliferation; Cell Survival; Curcumin; Hematology, Oncology and Palliative Medicine; Humans; Neoplastic Stem Cells - drug effects; Neoplastic Stem Cells - physiology; Phytochemicals; Phytochemicals - pharmacology; Phytochemicals - therapeutic use; Plant Extracts - pharmacology; Plant Extracts - therapeutic use; Signal Transduction - drug effects; Signaling pathways; Signaling pathways; Breast cancer; Curcumin; Phytochemicals; Cancer stem cells
• ISSN: 1044-579X; 1096-3650
• DOI: 10.1016/j.semcancer.2016.09.001

Abstract Breast cancer is the most common form of cancer diagnosed in women worldwide and the second leading cause of cancer-related deaths in the USA. Despite the development of newer diagnostic methods, selective as well as targeted chemotherapies and their combinations, surgery, hormonal therapy, radiotherapy, breast cancer recurrence, metastasis and drug resistance are still the major problems for breast cancer. Emerging evidence suggest the existence of cancer stem cells (CSCs), a population of cells with the capacity to self-renew, differentiate and be capable of initiating and sustaining tumor growth. In addition, CSCs are believed to be responsible for cancer recurrence, anticancer drug resistance, and metastasis. Hence, compounds targeting breast CSCs may be better therapeutic agents for treating breast cancer and control recurrence and metastasis. Naturally occurring compounds, mainly phytochemicals have gained immense attention in recent times because of their wide safety profile, ability to target heterogeneous populations of cancer cells as well as CSCs, and their key signaling pathways. Therefore, in the present review article, we summarize our current understanding of breast CSCs and their signaling pathways, and the phytochemicals that affect these cells including curcumin, resveratrol, tea polyphenols (epigallocatechin-3-gallate, epigallocatechin), sulforaphane, genistein, indole-3-carbinol, 3, 3′-di-indolylmethane, vitamin E, retinoic acid, quercetin, parthenolide, triptolide, 6-shogaol, pterostilbene, isoliquiritigenin, celastrol, and koenimbin. These phytochemicals may serve as novel therapeutic agents for breast cancer treatment and future leads for drug development.